Covenant Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
+2,931
| New | +$256K | 0.08% | 121 |
|
|
2023
Q3 | – | Sell |
-4,290
| Closed | -$551K | – | 186 |
|
|
2023
Q2 | $551K | Buy |
4,290
+108
| +3% | +$13.9K | 0.2% | 87 |
|
|
2023
Q1 | $486K | Buy |
4,182
+92
| +2% | +$10.7K | 0.19% | 91 |
|
|
2022
Q4 | $463K | Buy |
4,090
+257
| +7% | +$29.1K | 0.19% | 95 |
|
|
2022
Q3 | $309K | Buy |
+3,833
| New | +$309K | 0.15% | 124 |
|
|
2022
Q2 | – | Sell |
-3,220
| Closed | -$412K | – | 184 |
|
|
2022
Q1 | $412K | Sell |
3,220
-136
| -4% | -$17.4K | 0.16% | 124 |
|
|
2021
Q4 | $451K | Hold |
3,356
| – | – | 0.17% | 128 |
|
|
2021
Q3 | $459K | Hold |
3,356
| – | – | 0.18% | 116 |
|
|
2021
Q2 | $358K | Buy |
+3,356
| New | +$358K | 0.14% | 151 |
|